Swedish Orphan Biovitrum AB (publ) / Fundamentals
Income statement
- Net revenue
€2.47B - Cost of goods sold
€535.37M - Gross profit
€1.93B - SG&A expenses
€886.83M - R&D expenses
€321.09M - EBITDA
€891.67M - D&A
€336.82M - EBIT
€554.94M - Interest expenses
€73.53M - EBT
€460.83M - Tax expenses
€61.82M - Net income
€399.84M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€105.45M - Changes in working capital
-€86.33M - Operating cash flow
€616.49M - Capex
€244.46M - Other investing cash flow
-€250.95M - Net investing cash flow
-€257.99M - Total cash dividends paid
€0.00 - Issuance of common stock
€15.91M - Debt repayment
-€395.45M - Other financing cash flow
€52.95M - Net financing cash flow
-€326.58M - Foreign exchange effects
-€6.49M - Net change in cash
€25.52M - Cash at end of period
€96.76M - Free cash flow
€860.94M
Balance sheet
- Cash and cash equivalents
€96.76M - Cash and short-term investments
€96.76M - Total receivables
€638.71M - Inventory
€389.41M - Other current assets
€0.00 - Total current assets
€1.12B - Property, plant & equipment
€149.53M - Goodwill
€849.51M - Intangible assets
€4.04B - Long-term investments
€13.90M - Other non-current assets
€20.49M - Total non-current assets
€5.16B - Total assets
€6.29B - Accounts payable
€91.18M - Short-term debt
€368.01M - Other current liabilities
€663.22M - Total current liabilities
€1.12B - Long-term debt
€803.79M - Deferred tax liabilities
€563.63M - Other non-current liabilities
€224.70M - Total non-current liabilities
€1.59B - Total liabilities
€2.71B - Common stock
€17.83M - Retained earnings
€2.14B - Other equity
-€174.04M - Total equity
€3.57B - Total liabilities and shareholders' equity
€6.29B
Company information
- Market capitalization
€8.75B - Employees
1.9K - Enterprise Value
€113.52B
Company ratios
- Gross margin
-
78.3% Much better than peer group: 34.0% - EBITDA margin
-
36.2% Much better than peer group: 14.1% - EBIT margin
-
22.5% Better than peer group: 10.7% - EBT margin
-
18.7% Better than peer group: 9.2% - Net margin
-
16.2% Better than peer group: 6.7% - ROE
-
11.2% Even with peer group: 12.3% - ROA
-
6.4% Even with peer group: 4.7% - Asset turnover
-
39.2% Much worse than peer group: 69.4% - FCF margin
-
15.1% Better than peer group: 6.4% - FCF yield
4.3% - Efficiency ratio
63.8% - Net sales per employee
-
€1.30M - Net income per employee
-
€210.99K